| Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery G Unsoy, R Khodadust, S Yalcin, P Mutlu, U Gunduz European Journal of Pharmaceutical Sciences 62, 243-250, 2014 | 348 | 2014 |
| Bioapplications of poly (amidoamine)(PAMAM) dendrimers in nanomedicine N Taghavi Pourianazar, P Mutlu, U Gunduz Journal of Nanoparticle Research 16, 1-38, 2014 | 169 | 2014 |
| Loading of Gemcitabine on chitosan magnetic nanoparticles increases the anti-cancer efficacy of the drug M Parsian, G Unsoy, P Mutlu, S Yalcin, A Tezcaner, U Gunduz European journal of pharmacology 784, 121-128, 2016 | 118 | 2016 |
| Chitosan magnetic nanoparticles for pH responsive Bortezomib release in cancer therapy G Unsoy, S Yalcin, R Khodadust, P Mutlu, O Onguru, U Gunduz Biomedicine & Pharmacotherapy 68 (5), 641-648, 2014 | 84 | 2014 |
| Idarubicin-loaded folic acid conjugated magnetic nanoparticles as a targetable drug delivery system for breast cancer U Gunduz, T Keskin, G Tansık, P Mutlu, S Yalcın, G Unsoy, A Yakar, ... Biomedicine & Pharmacotherapy 68 (6), 729-736, 2014 | 74 | 2014 |
| Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery M Parsian, P Mutlu, S Yalcin, A Tezcaner, U Gunduz International Journal of Pharmaceutics 515 (1-2), 104-113, 2016 | 56 | 2016 |
| Multidrug resistance mediated by MRP1 gene overexpression in breast cancer patients OD Abaan, PK Mutlu, Y Baran, C Atalay, U Gunduz Cancer investigation 27 (2), 201-205, 2009 | 33 | 2009 |
| Polyhydroxybutyrate-coated magnetic nanoparticles for doxorubicin delivery: Cytotoxic effect against doxorubicin-resistant breast cancer cell line S Yalcin, G Unsoy, P Mutlu, R Khodadust, U Gunduz American journal of therapeutics 21 (6), 453-461, 2014 | 30 | 2014 |
| Poly amidoamine PAMAM nanoparticles: synthesis and biomedical applications NTP Azar, P Mutlu, R Khodadust, U Gunduz Hacettepe Journal of Biology and Chemistry 41 (3), 289-299, 2013 | 29 | 2013 |
| An update on molecular biology and drug resistance mechanisms of multiple myeloma P Mutlu, Y Kiraz, U Gündüz, Y Baran Critical reviews in oncology/hematology 96 (3), 413-424, 2015 | 22 | 2015 |
| Differential gene expression analysis related to extracellular matrix components in drug-resistant RPMI-8226 cell line P Mutlu, AU Ural, U Gündüz Biomedicine & Pharmacotherapy 66 (3), 228-231, 2012 | 20 | 2012 |
| Characterization of gemcitabine loaded polyhydroxybutyrate coated magnetic nanoparticles for targeted drug delivery M Parsian, P Mutlu, S Yalcin, U Gunduz Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2020 | 17 | 2020 |
| Detection of XRCC1 gene polymorphisms in Turkish head and neck squamous cell carcinoma patients: a comparative analysis with different populations P Mutlu, M Mutlu, S Yalcin, G Unsoy, A Yaylaci, G Saylam, I Akin IMPRIMATUR PUBLICATIONS, 2015 | 14 | 2015 |
| Effect of cobalt‐60 (γ radiation) on multidrug‐resistant multiple myeloma cell lines P Mutlu, Y Baran, AU Ural, F Avcu, B Dirican, M Beyzadeoglu, U Gündüz Cell Biology International 35 (7), 721-725, 2011 | 14 | 2011 |
| Identification of XRCC1 Arg399Gln and XRCC3 Thr241Met polymorphisms in a Turkish population and their association with the risk of chronic lymphocytic leukemia P Mutlu, MP Elçi, M Yıldırım, O Nevruz, AT Çetin, F Avcu Indian Journal of Hematology and Blood Transfusion 31, 332-338, 2015 | 12 | 2015 |
| Polyinosinic: polycytidylic acid loading onto different generations of PAMAM dendrimer-coated magnetic nanoparticles R Khodadust, P Mutlu, S Yalcın, G Unsoy, U Gunduz Journal of nanoparticle research 15, 1-12, 2013 | 10 | 2013 |
| The-137G/C polymorphism in interleukin-18 gene promoter contributes to chronic lymphocytic and chronic myelogenous leukemia risk in Turkish patients S Yalçın, P Mutlu, T Çetin, M Sarper, G Özgür, F Avcu Turkish Journal of Hematology 32 (4), 311, 2015 | 9 | 2015 |
| Association of-174G/C interleukin/6 gene polymorphism with the risk of chronic lymphocytic, chronic myelogenous and acute myelogenous leukemias in Turkish patients. P Mutlu, S Yalcin, P Elci, M Yildirim, AT Cetin, F Avcu Journal of BU ON.: Official Journal of the Balkan Union of Oncology 19 (3 …, 2014 | 9 | 2014 |
| Design, synthesis, molecular docking and ADME studies of novel indole-thiazolidinedione derivatives and their antineoplastic activity as CDK6 inhibitors Z Ates-Alagoz, MM Kisla, FZ Karadayi, S Baran, TS Doğan, P Mutlu New Journal of Chemistry 45 (38), 18025-18038, 2021 | 8 | 2021 |
| Synthesis, Anticancer Activity, and In Silico Modeling of Alkylsulfonyl Benzimidazole Derivatives: Unveiling Potent Bcl-2 Inhibitors for Breast Cancer Y Abbade, MM Kisla, MAK Hassan, I Celik, TS Dogan, P Mutlu, ... ACS omega 9 (8), 9547-9563, 2024 | 7 | 2024 |
